ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Journal and News Scan

Source: Journal of Clinical Oncology
Author(s): Hideki Ujiie, Kyuichi Kadota, Jamie E. Chaft, Daniel Buitrago, Camelia S. Sima, Ming-Ching Lee, James Huang, William D. Travis, Nabil P. Rizk, Charles M. Rudin, David R. Jones and Prasad S. Adusumilli

This single institution retrospective study evaluated the relationship of adenocarcinoma subtype to long-term survival after resection of stage I lung cancer.  Patients with solid-predominant tumors experienced recurrences earlier, more often in distant sites, and more often in multiple locations.  This subtype was also independently associated with worse post-recurrence survival.

Source: Journal of the American College of Surgeons
Author(s): Haruhiro Inoue, Hiroki Sato, Haruo Ikeda, Manabu Onumaru, Chiaki Sato, Hitomi Minami, Hiroshi Yokomichi, Yasutoshi Kobayashi, Kevin L. Grimes, Shin-ei Kudo

Case series of 500 consecutive patients undergoing POEM from September 2008 through November 2013 at a tertiary referral center in Japan.  At 2 month follow-up, the success rate was 91.3% (defined as Eckardt score < 2 or reduced > 4 points). Two hundred sixty-eight patients had esophagitis on endoscopy (64.7%), but only 71 (16.8%) had reflux symptoms. At 1-2 years, the success rate was 91%, 9 of 16 patients has esophagitis on endoscopy, and 19.4% had heartburn symptoms. Lastly, at 3 years the success rate was 88.5%, again 9 of 16 patients had esophagitis on endoscopy, and 56.3% had heartburn symptoms. Complications occurred in 16 patients (3.2%), the most severe being 1 pneumothorax requiring a chest tube and 1 case of bleeding controlled endoscopically but requiring blood transfusion; there were no deaths. The authors point out that one advantage of POEM over Heller myotomy is that the length of the myotomy can be better tailored to the individual patient. 

Source: Journal of Thoracic and Cardiovascular Surgery
Author(s): Nikhil Prakash Patil, Prashant N. Mohite, Anton Sabashnikov, Dhruva Dhar, Alexander Weymann, Mohamed Zeriouh, Rachel Hards, Michael Hedger, Fabio De Robertis, Toufan Bahrami, Mohamed Amrani, Shelley Rahman-Haley, Nicholas R. Banner, Aron Frederik Popov, André Rüdiger Simon

This retrospective analysis of the BTT continuous flow (CF) LVAD experience from Harefield Hospital addresses the question: "What are the predictors of the requirement for an RVAD at the time of LVAD implantation?" Of the 152 patients included in the study, 23% underwent RVAD implantation.  Of all the univariate predictors of the requirement of an RVAD, the two significant independent variables on multivariate analysis were the preop TAPSE (tricuspid annular plane systolic excursion) and the left atrial diameter.  Of note, a TAPSE value of <12.5 mm had an 84% sensitivity and 75% specificity for predicting the requirement for an RVAD.

Source: JACC Cardiovascular Interventions
Author(s): Barbanti M, Petronio AS, Ettori F, Latib A, Bedogni F, De Marco F, Poli A, Boschetti C, De Carlo M, Fiorina C, Colombo A, Brambilla N, Bruschi G, Martina P, Pandolfi C, Giannini C, Curello S, Sgroi C, Gulino S, Patanè M, Ohno Y, Tamburino C, Attizzani GF, Immè S, Gentili A, Tamburino C.

In this manuscript the authors describe their findings in a retrospective review of prospectively obtained 5-year follow up data on 353 patients undergoing transcatheter aortic valve implantation (TAVI) with the CoreValve prosthesis in 8 Italian centres.Transfemoral access was used in 317 patients (89.8%); in the rest of the patients in whom the transfemoral approach was  not feasible, a trans-subclavian access was employed. During follow-up, there were 241 re-hospitalizations for cardiovascular reasons in 164 (46%) patients. Acute heart failure was the most frequently reason reported (42.7%), followed by requirement of permanent pacemaker implantation (17.4%). On transthoracic echocardiography, mean pressure gradients decreased from 55.6 ±16.8 mm Hg (pre-TAVI) to 10.3±6.5 mm Hg (in-hospital post-TAVI) (p < 0.001). Five-year survival was 45% and freedom from re-hospitalization for cardiac reasons was 54%. Signs of prosthetic failure were observed in 15 patients (4.2%). The presence of moderate or severe paravalvular regurgitation after TAVI was associated with increased late mortality. The authors concluded that the procedure appears to be an adequate and lasting resolution of aortic stenosis in selected high-risk patients.

Source: Circulation
Author(s): Vejlstrup N, Sørensen K, Mattsson E, Thilén U, Kvidal P, Johansson B, Iversen K, Søndergaard L, Dellborg M, Eriksson P.

The authors evaluated long-term outcomes of 468 patients who have undergone a Mustard- or Senning operation for transposition of the great arteries (TGA). They found that perioperative mortality was 30%, but 60% were still alive after 30 years of follow-up. Perioperative mortality increased with the presence of a ventricular septum defect, early experience with the procedure, and left-ventricular outflow obstruction After patients had survived the postoperative period, only pacemaker implantation was a predictor of long-term outcome (HR=1.90, p=0.04). 

Source: Annals of Oncology
Author(s): P. Baas, D. Fennell, K. M. Kerr, P. E. Van Schil, R. L. Haas and S. Peters on behalf of the ESMO Guidelines Committee

The ESMO Guidelines Committee provides an update to its guidelines for evaluation and management of malignant pleural mesothelioma.  They recommend against screening.  A biopsy demonstrating tissue invasion is required for a definitive diagnosis.  Definitions for different extents of surgical radicality are provided.  No specific recommendations for the extent of surgery are provided, indicating the presence of equipoise at this time.

Source: Annals of Thoracic Surgery
Author(s): Kenan W. Yount, Christine L. Lau, Leora T. Yarboro, Ravi K. Ghanta, Irving L. Kron, John A. Kern, Gorav Ailawadi

The University of Virginia group retrospectively analyzed all non-emergent cardiac cases performed at their center from 2008 to 2013, and separated the  nonemergent cases into two groups:  "Early start" cases had an incision time before 3 PM, and "late start" cases, after 3 PM.  After controlling for case type, surgeon, year, and risk, late cases resulted in greater than double the operative mortality of early cases.

Source: AACN Advanced Critical Care
Author(s): S Jill Ley and Deirdre Koulakis

This article offers a much needed comprehensive overview of temporary pacing strategies specific to cardiac surgical patients.  In addition to discussing standard pacing content such as device settings and connections, it offers strategies and rationale for epicardial pacing unique to this population, as well as clear depictions of unipolar versus bipolar lead systems and an introduction to biventricular temporary pacing.  Content regarding use of atrial pacing wires for performing atrial ECG's and rapid atrial pacing of arrhythmias are well described.  This paper is an excellent resource for both basic and advanced cardiac surgical providers that will be widely reviewed. 

Source: European Heart Journal
Author(s): Stone GW, Vahanian AS, Adams DH, Abraham WT, Borer JS, Bax JJ, Schofer J, Cutlip DE, Krucoff MW, Blackstone EH, Généreux P, Mack MJ, Siegel RJ, Grayburn PA, Enriquez-Sarano M, Lancellotti P, Filippatos G, Kappetein AP; Mitral Valve Academic Research Consortium (MVARC)

Clinical trials evaluating transcatheter mitral valve interventions for severe mitral regurgitation (MR) are complex. The Mitral Valve Academic Research Consortium has provided a 2-part document with recommendations related to diagnosis of MR, patient selection for trials, trial designs and endpoint definitions that are instrumental for the evaluation of all treatments related to severe MR.

Source: Journal of Clinical Oncology
Author(s): Sheraz Markar, Caroline Gronnier, Alain Duhamel, Arnaud Pasquer, Jérémie Théreaux, Mael Chalret du Rieu, Jérémie H. Lefevre, Kathleen Turner, Guillaume Luc and Christophe Mariette

This multicenter retrospective study evaluated the efficacy of salvage esophagectomy after definitive chemoradiotherapy compared to planned esophagectomy after induction chemoradiotherapy.  Operative mortality was similarly high in both groups (8.4% vs 9.3%).  Anastomotic leak was higher after salvage esophagectomy (17.2% vs 10.7%).  3-year survival was similar between the groups.  Salvage esophagectomy for persistent disease resulted in lower survival than when performed for recurrent disease.

Pages